OrthoPediatrics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	148.73	122.29	98.05	71.08	72.55	57.56	45.62	37.3	31	23.68
Revenue Growth (YoY)	21.62%	24.72%	37.95%	-2.03%	26.05%	26.17%	22.31%	20.30%	30.91%	-
Cost of Revenue	37.48	31.63	24.65	16.05	17.93	14.88	11.17	10.93	9.37	7.09
Gross Profit	111.25	90.66	73.4	55.03	54.62	42.68	34.45	26.37	21.64	16.6
Selling, General & Admin	126.82	104.44	85.73	70.17	57.95	47.5	37.5	28.29	26.44	22.06
Research & Development	10.2	8.01	5.54	5.27	5.75	4.73	3.42	2.22	1.79	1.68
Other Operating Expenses	0.99	3.61	0.15	6.32	0.07	0.22	-0.03	0.95	0.03	0.07
Operating Expenses	138	116.06	91.43	81.77	63.77	52.45	40.89	31.46	28.26	23.81
Operating Income	-26.75	-25.4	-18.02	-26.74	-9.15	-9.77	-6.44	-5.1	-6.62	-7.21
Interest Expense / Income	-0.2	2.42	2.25	3.41	3.54	2.26	2.49	1.48	1.23	2.55
Other Expense / Income	-5.24	-24.13	-2.88	3.52	1.05	-	14.6	5.88	4.84	3.04
Pretax Income	-21.31	-3.69	-17.39	-33.67	-13.73	-12.03	-23.53	-12.45	-12.69	-12.8
Income Tax	-0.34	-4.95	-1.13	-0.72	0	0	0	0	0	0
Net Income	-20.97	1.26	-16.26	-32.94	-13.73	-12.03	-23.53	-12.45	-12.69	-12.8
Shares Outstanding (Basic)	23	21	19	18	15	13	4	2	2	2
Shares Outstanding (Diluted)	23	21	19	18	15	13	4	2	2	2
Shares Change	8.25%	8.72%	6.71%	23.47%	16.37%	212.83%	130.30%	-	0.00%	-
EPS (Basic)	-0.92	0.06	-0.84	-1.82	-0.94	-0.96	-5.86	-7.14	-7.27	-7.34
EPS (Diluted)	-0.92	0.06	-0.84	-1.82	-0.94	-0.96	-5.86	-7.14	-7.27	-7.34
Free Cash Flow	-43.92	-31.8	-21.17	-29.03	-29.59	-20.84	-12.42	-5.47	-3.1	-13.06
Free Cash Flow Per Share	-1.94	-1.54	-1.10	-1.61	-2.02	-1.66	-3.09	-3.13	-1.78	-7.49
Gross Margin	74.80%	74.14%	74.86%	77.42%	75.28%	74.15%	75.52%	70.69%	69.79%	70.09%
Operating Margin	-17.99%	-20.77%	-18.38%	-37.61%	-12.61%	-16.97%	-14.12%	-13.66%	-21.36%	-30.45%
Profit Margin	-14.10%	1.03%	-16.58%	-46.35%	-18.93%	-20.89%	-51.58%	-33.37%	-40.92%	-54.06%
Free Cash Flow Margin	-29.53%	-26.00%	-21.59%	-40.85%	-40.78%	-36.20%	-27.23%	-14.66%	-10.01%	-55.16%
EBITDA	-4.13	11.83	-4.46	-22.25	-5.52	-6.88	-18.64	-9.07	-9.6	-8.68
EBITDA Margin	-2.77%	9.68%	-4.55%	-31.30%	-7.61%	-11.95%	-40.85%	-24.32%	-30.98%	-36.64%
Depreciation & Amortization	17.39	13.1	10.68	8.01	4.67	2.89	2.41	1.9	1.85	1.58
EBIT	-21.51	-1.27	-15.14	-30.26	-10.19	-9.77	-21.04	-10.97	-11.46	-10.26
EBIT Margin	-14.46%	-1.03%	-15.44%	-42.57%	-14.05%	-16.97%	-46.12%	-29.42%	-36.96%	-43.30%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).